CRO/CDMO providing drug discovery, preclinical, and clinical development services
Nuvisan is a mid-sized CRO/CDMO operating across drug discovery, preclinical testing, clinical trials, bioanalysis, and manufacturing—structured around specialized service lines (research-heavy hiring, clinical investigators, quality/regulatory roles). The tech stack reflects lab-centric operations: LC-MS/MS, HPLC, Phoenix WinNonlin for pharmacokinetics, KNIME for data workflows, alongside standard enterprise tools. Active projects signal expansion into iPSC-based assays and in vitro/in vivo data integration, while pain points around quality documentation, audit readiness, and regulatory compliance dominate the near-term roadmap.
Notable leadership hires: Lab Head
Nuvisan is a contract research and manufacturing organization serving pharma clients across Europe and North America. The company provides end-to-end support from target validation and preclinical work through clinical development, CMC (chemistry, manufacturing, controls), and bioanalytical services. Operations span drug studies, GxP-qualified manufacturing, animal model work, and iPSC-based assay development for neurodegeneration and pain indications. The organization is structured around research and clinical delivery, with dedicated manufacturing, quality, and regulatory functions to support customer audits and regulatory inspections.
Nuvisan deploys LC-MS/MS, HPLC, and HPLC-MS/MS for bioanalysis; Phoenix WinNonlin for pharmacokinetic modeling; and KNIME for data workflows. Java and Python support internal analytical pipelines.
Nuvisan is actively recruiting in Germany (headquarters location), France, and the United States, with research and clinical roles across all three markets.
Other companies in the same industry, closest in size